Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
STEMCELL Technologies UM729, Size: 250 µg
Supplier: STEMCELL Technologies 72332
UM729 is a pyrimido-[4,5-b]-indole derivative which enhances the self-renewal of human hematopoietic stem cells in vitro. UM729 does not inhibit the aryl hydrocarbon receptor (AHR) pathway, but has been shown to collaborate with AHR antagonists in preventing differentiation of acute myeloid leukemia (AML) cells in culture.MAINTENANCE AND SELF-RENEWAL· Enhances human hematopoietic stem cell self-renewal in vitro (Fares et al.).CANCER RESEARCH:· Collaborates with StemRegenin 1 (SR1) in preventing differentiation of AML cells in culture (Pabst et al.).For clinical use of UM729, please contact ExCellThera.
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?